Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma.
Corren J, Castro M, Chanez P, Fabbri L, Joish VN, Amin N, Graham NMH, Mastey V, Abbé A, Taniou C, Mahajan P, Teper A, Pirozzi G, Eckert L.
Corren J, et al. Among authors: mahajan p.
Ann Allergy Asthma Immunol. 2019 Jan;122(1):41-49.e2. doi: 10.1016/j.anai.2018.08.005. Epub 2018 Aug 21.
Ann Allergy Asthma Immunol. 2019.
PMID: 30138668
Free article.
Clinical Trial.